Skip to main content
. 2022 Feb 13;12(2):477. doi: 10.3390/diagnostics12020477

Figure 2.

Figure 2

The figure shows the distribution of PD-L1 expression (as CPS) of the 22C3 pharmaDx, on Dako Autostainer link48 (L48) and Dako Omnis (O), and of SP263 assay for the different CPS cut-offs (<1; between 1 and 20 and >20).